Drug Interactions & Safety at 6th Annual Conference on Psychedelics and Psychedelic Medicine

2 sessions on drug interactions & safety · November 13–14, 2026, Boston, MA. Compare drug interactions & safety at other meetings →

Saturday, November 14

  • 11:20–11:50 · Lecture · Module 5: Culture & Naturalistic Risk

    Population-Level Risks in Naturalistic Psychedelic Use

    Grant Jones

    Reviews population-level risks associated with naturalistic psychedelic use.

    Psychedelics

  • 14:20–14:50 · Lecture · Module 6: Experience, Meaning, and Clinical Risk

    Clinical Risks and Adverse Outcomes in Psychedelic Therapies

    Kelley O’Donnell

    Reviews clinical risks and adverse outcomes associated with psychedelic therapies.

    Psychedelics

Other topics at this meeting

Psychedelics 17Neuroscience & Mechanisms 6Psychotherapy 4Ketamine & Esketamine 2Medical Comorbidity & C-L Psychiatry 2Depression 1Diverse & Underserved Populations 1Lifestyle & Integrative Psychiatry 1Personality Disorders 1Drug Pipeline & Clinical Trials 1Practice, Policy & Workforce 1Treatment-Resistant Depression 1

Full program overview →